主講人為羅格斯大學醫療保健政策與老齡化研究中心副研究員，庫珀曼巴拿巴斯醫院病毒性肝炎計畫及亞洲健康中心醫療主任，家庭醫師汪思涵（Su Wang, MD, MPH, FACP）。本次講座的一大亮點，是講座於FDA批准首款同類慢性B型肝炎治療藥物前舉行，為華人社區帶來了最新的醫學資訊與研發進展。讓社區民眾得以及時了解B型肝炎治療領域的重要新進展，充分體現了RWJBarnabas Health華人醫療服務部致力於以最快的速度傳遞前沿醫療資訊、提供專業健康教育的使命，也讓這場講座更具意義。
One of the highlights of the webinar was its exceptional timing. Just right before the new hepatitis B drug became available, FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment. Dr. Su Wang shared the latest medical updates and developments in hepatitis B research with the Chinese community. This timely presentation provided community members with early access to important information about advances in hepatitis B treatment, highlighting RWJBarnabas Health Chinese Navigation Program’ commitment to delivering timely, reliable, and up-to-date medical information and health education to the community.